85
Participants
Start Date
June 5, 2023
Primary Completion Date
December 16, 2028
Study Completion Date
December 16, 2028
Luspatercept
Specified dose on specified days
Local Institution - 0001, New Delhi
Local Institution - 0010, Delhi
Local Institution - 0004, Chandigarh
Local Institution - 0002, Ahmedabad
Local Institution - 0008, Mumbai
Local Institution - 0006, Hyderabad
Local Institution - 0003, Bangalore
Local Institution - 0007, Kolkata
Local Institution - 0005, Assam
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY